AllianceBernstein’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,383
| Closed | -$98.8K | – | 3273 |
|
|
2024
Q1 | $98.8K | Hold |
6,383
| – | – | ﹤0.01% | 3030 |
|
|
2023
Q4 | $179K | Hold |
6,383
| – | – | ﹤0.01% | 3000 |
|
|
2023
Q3 | $304K | Buy |
6,383
+1,178
| +23% | +$89.9K | ﹤0.01% | 2800 |
|
|
2023
Q2 | $499K | Hold |
5,205
| – | – | ﹤0.01% | 2638 |
|
|
2023
Q1 | $590K | Hold |
5,205
| – | – | ﹤0.01% | 2481 |
|
|
2022
Q4 | $583K | Hold |
5,205
| – | – | ﹤0.01% | 2548 |
|
|
2022
Q3 | $668K | Buy |
5,205
+560
| +12% | +$57.4K | ﹤0.01% | 2505 |
|
|
2022
Q2 | $319K | Buy |
4,645
+810
| +21% | +$69.8K | ﹤0.01% | 2853 |
|
|
2022
Q1 | $546K | Buy |
3,835
+15
| +0.4% | +$2.31K | ﹤0.01% | 2639 |
|
|
2021
Q4 | $636K | Sell |
3,820
-2,950
| -44% | -$469K | ﹤0.01% | 2640 |
|
|
2021
Q3 | $942K | Buy |
6,770
+2,430
| +56% | +$475K | ﹤0.01% | 2515 |
|
|
2021
Q2 | $2.07M | Buy |
4,340
+385
| +10% | +$162K | ﹤0.01% | 2167 |
|
|
2021
Q1 | $1.63M | Buy |
3,955
+105
| +3% | +$48.3K | ﹤0.01% | 2204 |
|
|
2020
Q4 | $1.89M | Buy |
3,850
+675
| +21% | +$395K | ﹤0.01% | 2023 |
|
|
2020
Q3 | $1.8M | Sell |
3,175
-1,795
| -36% | -$597K | ﹤0.01% | 1914 |
|
|
2020
Q2 | $473K | Buy |
4,970
+870
| +21% | +$76.3K | ﹤0.01% | 2648 |
|
|
2020
Q1 | $293K | Buy |
4,100
+700
| +21% | +$46.9K | ﹤0.01% | 2629 |
|
|
2019
Q4 | $235K | Hold |
3,400
| – | – | ﹤0.01% | 2866 |
|
|
2019
Q3 | $273K | Sell |
3,400
-195
| -5% | -$12.9K | ﹤0.01% | 2836 |
|
|
2019
Q2 | $232K | Buy |
3,595
+1,210
| +51% | +$115K | ﹤0.01% | 2917 |
|
|
2019
Q1 | $328K | Buy |
2,385
+165
| +7% | +$20.1K | ﹤0.01% | 2716 |
|
|
2018
Q4 | $201K | Sell |
2,220
-20
| -0.9% | -$2.8K | ﹤0.01% | 2888 |
|
|
2018
Q3 | $340K | Buy |
2,240
+70
| +3% | +$11.3K | ﹤0.01% | 2787 |
|
|
2018
Q2 | $373K | Buy |
2,170
+100
| +5% | +$16.3K | ﹤0.01% | 2722 |
|
|
2018
Q1 | $304K | Buy |
2,070
+75
| +4% | +$14.4K | ﹤0.01% | 2693 |
|
|
2017
Q4 | $405K | Sell |
1,995
-85
| -4% | -$17.5K | ﹤0.01% | 2601 |
|
|
2017
Q3 | $667K | Hold |
2,080
| – | – | ﹤0.01% | 2473 |
|
|
2017
Q2 | $470K | Buy |
2,080
+450
| +28% | +$92.4K | ﹤0.01% | 2643 |
|
|
2017
Q1 | $367K | Sell |
1,630
-90
| -5% | -$18.3K | ﹤0.01% | 2629 |
|
|
2016
Q4 | $341K | Hold |
1,720
| – | – | ﹤0.01% | 2690 |
|
|
2016
Q3 | $423K | Sell |
1,720
-19,117
| -92% | -$6.71M | ﹤0.01% | 2585 |
|
|
2016
Q2 | $12.1M | Sell |
20,837
-593
| -3% | -$348K | 0.01% | 841 |
|
|
2016
Q1 | $11.4M | Buy |
21,430
+2,523
| +13% | +$1.32M | 0.01% | 830 |
|
|
2015
Q4 | $13.3M | Buy |
+18,907
| New | +$12.4M | 0.01% | 809 |
|
Other funds holding MCRB
FP
TCM
AllianceBernstein's MCRB Position: Q2 2024 in Review
AllianceBernstein sold out of Seres Therapeutics (MCRB) in Q2 2024, closing a stake of 6,383 shares — an estimated $98.8K sold.
AllianceBernstein first reported a position in MCRB in Q4 2015 and held it in 34 quarters. The position peaked at $13.3M in Q4 2015. 93 funds tracked by Wall St. Rank hold MCRB as of Q2 2024.
- AllianceBernstein reported no remaining Seres Therapeutics position as of Q2 2024 after selling out during the quarter.
- AllianceBernstein sold 6,383 Seres Therapeutics shares in Q2 2024, an estimated $98.8K.
- AllianceBernstein first reported a position in Seres Therapeutics in Q4 2015 and held it in 34 quarters.
- AllianceBernstein's Seres Therapeutics position peaked at $13.3M in Q4 2015.
- 93 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2024.
Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.